{"transactions":[{"id":741513,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:37:43.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":4.12,"expiration_date":"2036-06-11","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-26-000072","document":"wk-form4_1781213861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034026000072/wk-form4_1781213861.xml","form_type":"4"}},{"id":935305,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-20T14:17:29.000Z","date":"2026-01-15","kind":"purchase","planned":false,"acquired":true,"shares":21645,"price":4.6681,"value":101041.0245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.61 to $4.69. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":74530,"source":{"system":"sec-edgar","filing":"0001790340-26-000014","document":"wk-form4_1768918646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034026000014/wk-form4_1768918646.xml","form_type":"4"}},{"id":1099198,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-30T13:09:20.000Z","date":"2025-06-27","kind":"purchase","planned":false,"acquired":true,"shares":9500,"price":3.6619,"value":34788.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.6 to $3.73. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":52885,"source":{"system":"sec-edgar","filing":"0001790340-25-000089","document":"wk-form4_1751288953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034025000089/wk-form4_1751288953.xml","form_type":"4"}},{"id":1106147,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-18T13:11:22.000Z","date":"2025-06-17","kind":"purchase","planned":false,"acquired":true,"shares":40485,"price":2.2052,"value":89277.522,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.16 to $2.24. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":43385,"source":{"system":"sec-edgar","filing":"0001790340-25-000079","document":"wk-form4_1750252275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034025000079/wk-form4_1750252275.xml","form_type":"4"}},{"id":1109691,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-16T13:15:35.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first."}],"balance_after":33350,"derivative":{"exercise_price":1.9,"expiration_date":"2035-06-13","underlying":"Class A Common Stock","underlying_shares":33350},"source":{"system":"sec-edgar","filing":"0001790340-25-000073","document":"wk-form4_1750079729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000179034025000073/wk-form4_1750079729.xml","form_type":"4"}},{"id":1480463,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-13T20:26:02.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first."}],"balance_after":8588,"derivative":{"exercise_price":1.54,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":8588},"source":{"system":"sec-edgar","filing":"0001628280-24-028072","document":"wk-form4_1718310353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000162828024028072/wk-form4_1718310353.xml","form_type":"4"}},{"id":1561809,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-03-25T20:03:33.000Z","date":"2024-03-22","kind":"purchase","planned":false,"acquired":true,"shares":2900,"price":2.5465,"value":7384.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.53 to $2.55. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":2900,"source":{"system":"sec-edgar","filing":"0001415889-24-009028","document":"form4-03252024_080319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000141588924009028/form4-03252024_080319.xml","form_type":"4"}},{"id":1580881,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-12T21:02:16.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a three year period commencing on April 11, 2024, and will be fully vested and exercisable on March 11, 2027."}],"balance_after":35000,"derivative":{"exercise_price":5.93,"expiration_date":"2034-03-11","underlying":"Class A Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-24-007651","document":"form4-03122024_090310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000141588924007651/form4-03122024_090310.xml","form_type":"4"}},{"id":2132925,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":239934,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":239934},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132924,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":27998,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":14.28,"underlying":"Common Stock","underlying_shares":27998},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132923,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":7002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":14.28,"underlying":"Common Stock","underlying_shares":7002},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132922,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":386769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":7.1,"underlying":"Common Stock","underlying_shares":386769},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132921,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":8231,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":7.1,"underlying":"Common Stock","underlying_shares":8231},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132920,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":13825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":8.19,"underlying":"Common Stock","underlying_shares":13825},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132919,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":406175,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":8.19,"underlying":"Common Stock","underlying_shares":406175},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132918,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":14188,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.57,"underlying":"Common Stock","underlying_shares":14188},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132917,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":285812,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.57,"underlying":"Common Stock","underlying_shares":285812},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132916,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":17569,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":6.62,"underlying":"Common Stock","underlying_shares":17569},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132915,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":262431,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":6.62,"underlying":"Common Stock","underlying_shares":262431},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132914,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":278307,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":10.86,"underlying":"Common Stock","underlying_shares":278307},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132913,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":11693,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":10.86,"underlying":"Common Stock","underlying_shares":11693},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132912,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":222088,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":11.02,"underlying":"Common Stock","underlying_shares":222088},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132911,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":7912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":11.02,"underlying":"Common Stock","underlying_shares":7912},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132910,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":68998,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":46.59,"underlying":"Common Stock","underlying_shares":68998},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132909,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":2502,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":46.59,"underlying":"Common Stock","underlying_shares":2502},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132908,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":188408,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":29.83,"underlying":"Common Stock","underlying_shares":188408},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132907,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":4192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":29.83,"underlying":"Common Stock","underlying_shares":4192},"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2132906,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-24T23:01:29.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":2393352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 3, 2022, among Amgen Inc. (\"Parent\"), Carnation Merger Sub, Inc. (\"Merger Sub\") and ChemoCentryx, Inc. (the \"Company\"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the \"Shares,\" and each such share, a \"Share\") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the \"Merger Consideration\"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-034075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000089924322034075/doc4.xml","form_type":"4"}},{"id":2191850,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-08T23:41:19.000Z","date":"2022-08-04","kind":"exercise","acquired":false,"shares":130000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of August 4, 2022, and prior to this transaction, the exercised options were fully vested."}],"balance_after":35000,"derivative":{"exercise_price":14.28,"expiration_date":"2023-07-23","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-22-044896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122044896/doc4.xml","form_type":"4"}},{"id":2191849,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-08-08T23:41:19.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":130000,"price":50.2441,"value":6531733.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $50.05 to $50.59 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2393352,"source":{"system":"sec-edgar","filing":"0001209191-22-044896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122044896/doc4.xml","form_type":"4"}},{"id":2191848,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-08-08T23:41:19.000Z","date":"2022-08-04","kind":"exercise","acquired":true,"shares":130000,"price":14.28,"value":1856400.0,"ownership":{"direct":true},"balance_after":2523352,"source":{"system":"sec-edgar","filing":"0001209191-22-044896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122044896/doc4.xml","form_type":"4"}},{"id":2371853,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-26T01:39:46.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":192600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on February 22, 2022, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date."}],"balance_after":192600,"derivative":{"exercise_price":29.83,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":192600},"source":{"system":"sec-edgar","filing":"0001209191-22-013403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122013403/doc4.xml","form_type":"4"}},{"id":2371852,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-02-26T01:39:46.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":152700,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units awarded on February 22, 2022, vests in four equal installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units awarded on February 22, 2022, vests in four equal installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":152700,"derivative":{"underlying":"Common Stock","underlying_shares":152700},"source":{"system":"sec-edgar","filing":"0001209191-22-013403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122013403/doc4.xml","form_type":"4"}},{"id":2448689,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-01-05T02:42:35.000Z","date":"2022-01-01","kind":"exercise","acquired":false,"shares":26333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock units awarded on February 25, 2021, vests in three equal installments on January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The restricted stock units awarded on February 25, 2021, vests in three equal installments on January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":52667,"derivative":{"underlying":"Common Stock","underlying_shares":26333},"source":{"system":"sec-edgar","filing":"0001209191-22-001341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122001341/doc4.xml","form_type":"4"}},{"id":2448688,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-01-05T02:42:35.000Z","date":"2022-01-01","kind":"exercise","acquired":false,"shares":34567,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":34567,"derivative":{"underlying":"Common Stock","underlying_shares":34567},"source":{"system":"sec-edgar","filing":"0001209191-22-001341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122001341/doc4.xml","form_type":"4"}},{"id":2448687,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-01-05T02:42:35.000Z","date":"2022-01-01","kind":"exercise","acquired":false,"shares":23334,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":23334},"source":{"system":"sec-edgar","filing":"0001209191-22-001341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122001341/doc4.xml","form_type":"4"}},{"id":2448686,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-05T02:42:35.000Z","date":"2022-01-01","kind":"tax_withholding","acquired":false,"shares":45698,"price":36.41,"value":1663864.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation."}],"balance_after":2393352,"source":{"system":"sec-edgar","filing":"0001209191-22-001341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122001341/doc4.xml","form_type":"4"}},{"id":2448685,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-05T02:42:35.000Z","date":"2022-01-01","kind":"exercise","acquired":true,"shares":26333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were acquired upon vesting of restricted stock units awarded on February 25, 2021."}],"balance_after":2439050,"source":{"system":"sec-edgar","filing":"0001209191-22-001341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122001341/doc4.xml","form_type":"4"}},{"id":2448684,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-05T02:42:35.000Z","date":"2022-01-01","kind":"exercise","acquired":true,"shares":34567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were acquired upon vesting of restricted stock units awarded on March 3, 2020."}],"balance_after":2412717,"source":{"system":"sec-edgar","filing":"0001209191-22-001341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122001341/doc4.xml","form_type":"4"}},{"id":2448683,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-05T02:42:35.000Z","date":"2022-01-01","kind":"exercise","acquired":true,"shares":23334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on March 4, 2019."}],"balance_after":2378150,"source":{"system":"sec-edgar","filing":"0001209191-22-001341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919122001341/doc4.xml","form_type":"4"}},{"id":2485554,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-04T00:39:41.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":6988,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of December 1, 2021, and prior to this transaction, the exercised options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":6988},"source":{"system":"sec-edgar","filing":"0001209191-21-068010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121068010/doc4.xml","form_type":"4"}},{"id":2485553,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-04T00:39:41.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":38948,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of December 1, 2021, and prior to this transaction, the exercised options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.27,"expiration_date":"2022-02-27","underlying":"Common Stock","underlying_shares":38948},"source":{"system":"sec-edgar","filing":"0001209191-21-068010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121068010/doc4.xml","form_type":"4"}},{"id":2485552,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-04T00:39:41.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":6988,"price":14.31,"value":99998.28,"ownership":{"direct":true},"balance_after":2354816,"source":{"system":"sec-edgar","filing":"0001209191-21-068010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121068010/doc4.xml","form_type":"4"}},{"id":2485551,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-04T00:39:41.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":38948,"price":10.27,"value":399995.96,"ownership":{"direct":true},"balance_after":2347828,"source":{"system":"sec-edgar","filing":"0001209191-21-068010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121068010/doc4.xml","form_type":"4"}},{"id":2826065,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T02:17:05.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":54600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on February 25, 2021, and 25% of the total number of shares of common stock subject to the option  vests on January 1, 2022, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date."}],"balance_after":54600,"derivative":{"exercise_price":65.87,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":54600},"source":{"system":"sec-edgar","filing":"0001209191-21-015531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121015531/doc4.xml","form_type":"4"}},{"id":2826064,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T02:17:05.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":79000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units awarded on February 25, 2021, vests in three equal installments on January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units awarded on February 25, 2021, vests in three equal installments on January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":79000,"derivative":{"underlying":"Common Stock","underlying_shares":79000},"source":{"system":"sec-edgar","filing":"0001209191-21-015531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121015531/doc4.xml","form_type":"4"}},{"id":2913603,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-01-08T01:40:05.000Z","date":"2021-01-01","kind":"exercise","acquired":false,"shares":34566,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":69134,"derivative":{"underlying":"Common Stock","underlying_shares":34566},"source":{"system":"sec-edgar","filing":"0001209191-21-002636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121002636/doc4.xml","form_type":"4"}},{"id":2913602,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-01-08T01:40:05.000Z","date":"2021-01-01","kind":"exercise","acquired":false,"shares":23333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":23334,"derivative":{"underlying":"Common Stock","underlying_shares":23333},"source":{"system":"sec-edgar","filing":"0001209191-21-002636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121002636/doc4.xml","form_type":"4"}},{"id":2913601,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-01-08T01:40:05.000Z","date":"2021-01-01","kind":"exercise","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units awarded on March 5, 2018, vest in three equal installments on January 1, 2019, January 1, 2020, and January 1, 2021, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units awarded on March 5, 2018, vest in three equal installments on January 1, 2019, January 1, 2020, and January 1, 2021, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-002636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121002636/doc4.xml","form_type":"4"}},{"id":2913600,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-08T01:40:05.000Z","date":"2021-01-01","kind":"tax_withholding","acquired":false,"shares":47576,"price":61.92,"value":2945905.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation."}],"balance_after":2308880,"source":{"system":"sec-edgar","filing":"0001209191-21-002636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121002636/doc4.xml","form_type":"4"}},{"id":2913599,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-08T01:40:05.000Z","date":"2021-01-01","kind":"exercise","acquired":true,"shares":34566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were acquired upon vesting of restricted stock units awarded on March 3, 2020."}],"balance_after":2356456,"source":{"system":"sec-edgar","filing":"0001209191-21-002636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121002636/doc4.xml","form_type":"4"}},{"id":2913598,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-08T01:40:05.000Z","date":"2021-01-01","kind":"exercise","acquired":true,"shares":23333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were acquired upon vesting of restricted stock units awarded on March 4, 2019."}],"balance_after":2321890,"source":{"system":"sec-edgar","filing":"0001209191-21-002636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121002636/doc4.xml","form_type":"4"}},{"id":2913597,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-08T01:40:05.000Z","date":"2021-01-01","kind":"exercise","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on March 5, 2018."}],"balance_after":2298557,"source":{"system":"sec-edgar","filing":"0001209191-21-002636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919121002636/doc4.xml","form_type":"4"}},{"id":2942327,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-17T00:51:17.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":17619,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As of December 14, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":6988,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":17619},"source":{"system":"sec-edgar","filing":"0001209191-20-063919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120063919/doc4.xml","form_type":"4"}},{"id":2942326,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-17T00:51:17.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":11153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As of December 14, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":24607,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":11153},"source":{"system":"sec-edgar","filing":"0001209191-20-063919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120063919/doc4.xml","form_type":"4"}},{"id":2942325,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-17T00:51:17.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":17619,"price":65.0122,"value":1145449.9518,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $64.99 to $65.16 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-063919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120063919/doc4.xml","form_type":"4"}},{"id":2942324,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-17T00:51:17.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":17619,"price":14.31,"value":252127.89,"ownership":{"direct":true},"balance_after":2286176,"source":{"system":"sec-edgar","filing":"0001209191-20-063919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120063919/doc4.xml","form_type":"4"}},{"id":2942323,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-17T00:51:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":11153,"price":65.027,"value":725246.131,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $64.99 to $65.20 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-063919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120063919/doc4.xml","form_type":"4"}},{"id":2942322,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-17T00:51:17.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":11153,"price":14.31,"value":159599.43,"ownership":{"direct":true},"balance_after":2279710,"source":{"system":"sec-edgar","filing":"0001209191-20-063919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120063919/doc4.xml","form_type":"4"}},{"id":3108787,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-17T00:20:32.000Z","date":"2020-06-15","kind":"exercise","acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As of June 12, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":35760,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-037135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120037135/doc4.xml","form_type":"4"}},{"id":3108786,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-17T00:20:32.000Z","date":"2020-06-12","kind":"exercise","acquired":false,"shares":88753,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As of June 12, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":37760,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":88753},"source":{"system":"sec-edgar","filing":"0001209191-20-037135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120037135/doc4.xml","form_type":"4"}},{"id":3108785,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-17T00:20:32.000Z","date":"2020-06-15","kind":"sale","acquired":false,"shares":2000,"price":65.0448,"value":130089.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $64.99 to $65.22 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-037135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120037135/doc4.xml","form_type":"4"}},{"id":3108784,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-17T00:20:32.000Z","date":"2020-06-15","kind":"exercise","acquired":true,"shares":2000,"price":14.31,"value":28620.0,"ownership":{"direct":true},"balance_after":2270557,"source":{"system":"sec-edgar","filing":"0001209191-20-037135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120037135/doc4.xml","form_type":"4"}},{"id":3108783,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-17T00:20:32.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":88753,"price":65.0781,"value":5775876.6093,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $64.99 to $65.39 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-037135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120037135/doc4.xml","form_type":"4"}},{"id":3108782,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-17T00:20:32.000Z","date":"2020-06-12","kind":"exercise","acquired":true,"shares":88753,"price":14.31,"value":1270055.43,"ownership":{"direct":true},"balance_after":2357310,"source":{"system":"sec-edgar","filing":"0001209191-20-037135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120037135/doc4.xml","form_type":"4"}},{"id":3152547,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-12","kind":"exercise","acquired":false,"shares":35865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of May 8, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":126513,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":35865},"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152546,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-11","kind":"exercise","acquired":false,"shares":70608,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of May 8, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":162378,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":70608},"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152545,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-08","kind":"exercise","acquired":false,"shares":4201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of May 8, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":232986,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":4201},"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152544,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":35865,"price":57.7471,"value":2071099.7415,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152543,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-12","kind":"exercise","acquired":true,"shares":35865,"price":14.31,"value":513228.15,"ownership":{"direct":true},"balance_after":2304422,"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152542,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":16029,"price":56.1404,"value":899874.4716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $56.00 to $56.39 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152541,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":54579,"price":55.33,"value":3019856.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $54.99 to $55.98 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2284586,"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152540,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-11","kind":"exercise","acquired":true,"shares":70608,"price":14.31,"value":1010400.48,"ownership":{"direct":true},"balance_after":2339165,"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152539,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":4201,"price":55.0142,"value":231114.6542,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $54.99 to $55.09 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3152538,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-12T23:50:34.000Z","date":"2020-05-08","kind":"exercise","acquired":true,"shares":4201,"price":14.31,"value":60116.31,"ownership":{"direct":true},"balance_after":2272758,"source":{"system":"sec-edgar","filing":"0001209191-20-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120028669/doc4.xml","form_type":"4"}},{"id":3158128,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-08T00:11:02.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":8851,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of May 5, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":237187,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":8851},"source":{"system":"sec-edgar","filing":"0001209191-20-027817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120027817/doc4.xml","form_type":"4"}},{"id":3158127,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-08T00:11:02.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":8851,"price":55.0052,"value":486851.0252,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $54.99 to $55.09 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-027817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120027817/doc4.xml","form_type":"4"}},{"id":3158126,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-08T00:11:02.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":8851,"price":14.31,"value":126657.81,"ownership":{"direct":true},"balance_after":2277408,"source":{"system":"sec-edgar","filing":"0001209191-20-027817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120027817/doc4.xml","form_type":"4"}},{"id":3224429,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-06T00:03:45.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":71500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option was granted on March 3, 2020, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2021, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date."}],"balance_after":71500,"derivative":{"exercise_price":46.59,"expiration_date":"2030-03-03","underlying":"Common Stock","underlying_shares":71500},"source":{"system":"sec-edgar","filing":"0001209191-20-016765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120016765/doc4.xml","form_type":"4"}},{"id":3224428,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-03-06T00:03:45.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":103700,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":103700,"derivative":{"underlying":"Common Stock","underlying_shares":103700},"source":{"system":"sec-edgar","filing":"0001209191-20-016765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120016765/doc4.xml","form_type":"4"}},{"id":3224427,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-06T00:03:45.000Z","date":"2020-03-04","kind":"exercise","acquired":false,"shares":40844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of March 4, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":246038,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":40844},"source":{"system":"sec-edgar","filing":"0001209191-20-016765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120016765/doc4.xml","form_type":"4"}},{"id":3224426,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-06T00:03:45.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":40844,"price":50.3548,"value":2056691.4512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $49.99 to $50.83 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-016765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120016765/doc4.xml","form_type":"4"}},{"id":3224425,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-06T00:03:45.000Z","date":"2020-03-04","kind":"exercise","acquired":true,"shares":40844,"price":14.31,"value":584477.64,"ownership":{"direct":true},"balance_after":2309401,"source":{"system":"sec-edgar","filing":"0001209191-20-016765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120016765/doc4.xml","form_type":"4"}},{"id":3256312,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-22T00:24:10.000Z","date":"2020-02-20","kind":"exercise","acquired":false,"shares":15341,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of February 19, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":286882,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":15341},"source":{"system":"sec-edgar","filing":"0001209191-20-011796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120011796/doc4.xml","form_type":"4"}},{"id":3256311,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-22T00:24:10.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":63340,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of February 19, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":302223,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":63340},"source":{"system":"sec-edgar","filing":"0001209191-20-011796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120011796/doc4.xml","form_type":"4"}},{"id":3256310,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-22T00:24:10.000Z","date":"2020-02-20","kind":"sale","acquired":false,"shares":29,"price":51.1,"value":1481.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-011796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120011796/doc4.xml","form_type":"4"}},{"id":3256309,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-22T00:24:10.000Z","date":"2020-02-20","kind":"sale","acquired":false,"shares":15312,"price":50.2099,"value":768813.9888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $49.99 to $50.92 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268586,"source":{"system":"sec-edgar","filing":"0001209191-20-011796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120011796/doc4.xml","form_type":"4"}},{"id":3256308,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-22T00:24:10.000Z","date":"2020-02-20","kind":"exercise","acquired":true,"shares":15341,"price":14.31,"value":219529.71,"ownership":{"direct":true},"balance_after":2283898,"source":{"system":"sec-edgar","filing":"0001209191-20-011796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120011796/doc4.xml","form_type":"4"}},{"id":3256307,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-22T00:24:10.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":7723,"price":51.143,"value":394977.389,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $50.99 to $51.36 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-011796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120011796/doc4.xml","form_type":"4"}},{"id":3256306,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-22T00:24:10.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":55617,"price":50.4079,"value":2803536.1743,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $49.99 to $50.97 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2276280,"source":{"system":"sec-edgar","filing":"0001209191-20-011796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120011796/doc4.xml","form_type":"4"}},{"id":3256305,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-22T00:24:10.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":63340,"price":14.31,"value":906395.4,"ownership":{"direct":true},"balance_after":2331897,"source":{"system":"sec-edgar","filing":"0001209191-20-011796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120011796/doc4.xml","form_type":"4"}},{"id":3286448,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-06T23:51:47.000Z","date":"2020-02-04","kind":"exercise","acquired":false,"shares":119525,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of February 4, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":365563,"derivative":{"exercise_price":14.31,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":119525},"source":{"system":"sec-edgar","filing":"0001209191-20-007294","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120007294/doc4.xml","form_type":"4"}},{"id":3286447,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-06T23:51:47.000Z","date":"2020-02-04","kind":"sale","acquired":false,"shares":119525,"price":45.1847,"value":5400701.2675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $44.99 to $45.61 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-007294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120007294/doc4.xml","form_type":"4"}},{"id":3286446,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-06T23:51:47.000Z","date":"2020-02-04","kind":"exercise","acquired":true,"shares":119525,"price":14.31,"value":1710402.75,"ownership":{"direct":true},"balance_after":2388082,"source":{"system":"sec-edgar","filing":"0001209191-20-007294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120007294/doc4.xml","form_type":"4"}},{"id":3307838,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-18T00:55:00.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":105735,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of January 16, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":38948,"derivative":{"exercise_price":10.27,"expiration_date":"2022-02-27","underlying":"Common Stock","underlying_shares":105735},"source":{"system":"sec-edgar","filing":"0001209191-20-004185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120004185/doc4.xml","form_type":"4"}},{"id":3307837,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-18T00:55:00.000Z","date":"2020-01-16","kind":"exercise","acquired":false,"shares":30317,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of January 16, 2020, and prior to this transaction, the exercised options were fully vested."}],"balance_after":144683,"derivative":{"exercise_price":10.27,"expiration_date":"2022-02-27","underlying":"Common Stock","underlying_shares":30317},"source":{"system":"sec-edgar","filing":"0001209191-20-004185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120004185/doc4.xml","form_type":"4"}},{"id":3307836,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-18T00:55:00.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":22179,"price":42.1299,"value":934399.0521,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $42.00 to $42.39 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-004185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120004185/doc4.xml","form_type":"4"}},{"id":3307835,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-18T00:55:00.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":83556,"price":41.4557,"value":3463872.4692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $40.99 to $41.98 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2290736,"source":{"system":"sec-edgar","filing":"0001209191-20-004185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120004185/doc4.xml","form_type":"4"}},{"id":3307834,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-18T00:55:00.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":105735,"price":10.27,"value":1085898.45,"ownership":{"direct":true},"balance_after":2374292,"source":{"system":"sec-edgar","filing":"0001209191-20-004185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120004185/doc4.xml","form_type":"4"}},{"id":3307833,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":39220,"kind":"person","name":"Schall Thomas J.","position":1,"cik":"0001423084","reported_name":"Schall Thomas J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-18T00:55:00.000Z","date":"2020-01-16","kind":"sale","acquired":false,"shares":30317,"price":41.0057,"value":1243169.8069,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $40.99 to $41.09 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":2268557,"source":{"system":"sec-edgar","filing":"0001209191-20-004185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423084/000120919120004185/doc4.xml","form_type":"4"}}],"next_cursor":"2020-01-18T00:55:00.000000Z,3307833"}